ARTICLE | Clinical News
VX-175: Phase II data; Phase III
February 12, 2001 8:00 AM UTC
Vertex Pharmaceuticals Inc. (VRTX), Cambridge, Mass. Product: VX-175 ( GW433908) Business: Infectious diseases Therapeutic category: Viral infection Target: HIV protease Description: Prodrug of Agen...